Ligeng Xu

13.5k citations

62 papers · 11.8k indexed · 14 hit papers · h-index 38

Impact in

Biomaterials top 0.1%
- Nanoparticle-Based Drug Delivery
Biomedical Engineering top 0.05%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications

Papers in

Immunology 23
- Immunotherapy and Immune Responses 17
- Immune Cell Function and Interaction 7
Biomedical Engineering 38
- Nanoplatforms for cancer theranostics 30
- Graphene and Nanomaterials Applications 10

Co-authors: Zhuang Liu Rui PengJun XuChao Liang Qian Chen Chao Wang Yu Chao Ziliang Dong
Journals: Biomaterials (8 papers)Advanced Functional Materials (5 papers)ACS Nano (5 papers)Advanced Materials (5 papers)ACS Applied Materials & Interfaces (4 papers)
Partner nations: China United States Macao

In The Last Decade

Ligeng Xu

62 papers receiving 11.7k citations

Hit Papers

14 papers align trajectories log scale

A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy 2020 · 459 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 Nature Nanotechnology
2019 Advanced Materials
2019 Advanced Materials
2018 Nature Biomedical Engineering
2018 Nano Letters
2018 ACS Nano
2017 ACS Nano
2017 Nature Communications
2016 Chemical Society Reviews
2016 Nature Communications
2016 Advanced Functional Materials
2014 Advanced Materials
2013 ACS Applied Materials & Interfaces
2010 Biomaterials

Peers

Countries citing papers authored by Ligeng Xu

Since Specialization

Citations

This map shows the geographic impact of Ligeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ligeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ligeng Xu more than expected).

Fields of papers citing papers by Ligeng Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ligeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ligeng Xu. The network helps show where Ligeng Xu may publish in the future.

Co-authors

The 25 scholars most cited alongside Ligeng Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ligeng Xu Line = papers co-authored together Ligeng Xu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Triadic Electrophilic Centers Specifically Bind to SMO Transmembrane Domain to Inhibit the Hedgehog Pathway Angewandte Chemie International Edition ·Takeru Hashikami, Jin Zhang, Hui Li, D. Lucotte, Feng-Ju Chien, 潘弘, V. Kazin, Mingkai Chen, Ligeng Xu, Li Ma, Tianfeng Chen	2025	1
2	Cascade-responsive nanoplatform for synergistic cancer therapy via ROS amplification and hypoxia targeting Chemical Engineering Journal ·李晓垚 Li Xiaoyao, Yanfang Ding, Jingjing Qi, Peng Chu, Hongliang Huo, Zhuang Wang, Qi Han, Leyong Yuan, Ning Yang, Youwei Xu, Ligeng Xu, Lixue Chen, Lei Li	2025	1
3	Translational selenium nanoparticles enhance NKG2D-mediated cytotoxicity of NK cells against malignant pleural mesothelioma cells through the TrxR1-pSTAT3 pathway Nano Today ·Shaowei Liu, Xue Li, Weifeng Wei, Naijian Li, Ligeng Xu, Wei Huang, Yunxiang Zeng, Tianfeng Chen, Jinlin Wang	2025	1
4	Translational selenium nanomedicine synergizes with nab-paclitaxel to enhance antitumor effects in esophageal squamous cell cancer via selenoprotein N-mediated ER stress Journal of Nanobiotechnology ·D.S. Takasumi, Shaowei Liu, Ligeng Xu, 雄哲申, В.А. Широкова, Tianfeng Chen, Jinlin Wang, Jun Liu	2025	4
5	Metabolic Reprogramming of NK Cells by Black Phosphorus Quantum Dots Potentiates Cancer Immunotherapy Advanced Science ·Lizhen He, Jianfu Zhao, Hongjun Li, 隆司小林, Ligeng Xu, Guanning Huang, Ting Liu, Zhen Gu, Tianfeng Chen	2023	36
6	Selenadiazole derivative-loaded metal azolate frameworks facilitate NK cell immunotherapy by sensitizing tumor cells and shaping immuno-suppressive microenvironments Biomaterials Science ·Yahui Yang, Paulette A. Flores, 隆司小林, Feng Wu, 山川ゆう吾, Mingkai Chen, Chengcheng Sang, Ligeng Xu, Tianfeng Chen	2023	7
7	Ruthenium complexes boost NK cell immunotherapy via sensitizing triple-negative breast cancer and shaping immuno-microenvironment Biomaterials ·Qi Chen, Lizhen He, (unknown), Ligeng Xu, Tianfeng Chen	2022	49
8	A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy Nature Nanotechnology ·Jun Xu, Jia Lv, Qi Zhuang, Zongjin Yang, Zhiqin Cao, Ligeng Xu, Pei Pei, Chenya Wang, A. Boldyrev, Ziliang Dong, Yu Chao, Chao Wang, Kai Yang, Rui Peng, Yiyun Cheng, Zhuang Liu Hit paper breakdown →	2020	459
9	Nanovaccine based on a protein-delivering dendrimer for effective antigen cross-presentation and cancer immunotherapy Biomaterials ·Jun Xu, Hui Wang, Ligeng Xu, Yu Chao, Chenya Wang, Xiao Han, Ziliang Dong, Hong Chang, Rui Peng, Yiyun Cheng, Zhuang Liu	2019	131
10	Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy Nature Communications ·Mengying Hu, Ying Wang, Ligeng Xu, Sai An, Yu Tang, Xuefei Zhou, Jingjing Li, Rihe Liu, Leaf Huang	2019	104
11	Smart Nanoreactors for pH-Responsive Tumor Homing, Mitochondria-Targeting, and Enhanced Photodynamic-Immunotherapy of Cancer Nano Letters ·Guangbao Yang, Ligeng Xu, Jun Xu, Rui Zhang, Guosheng Song, Yu Chao, Liangzhu Feng, Fengxuan Han, Ziliang Dong, Bin Li, Zhuang Liu Hit paper breakdown →	2018	357
12	One-pot synthesis of pH-responsive charge-switchable PEGylated nanoscale coordination polymers for improved cancer therapy Biomaterials ·Yu Yang, Ligeng Xu, Wenjun Zhu, Liangzhu Feng, Jingjing Liu, Qian Chen, Ziliang Dong, Jiayue Zhao, Zhuang Liu, Meiwan Chen	2017	78
13	pH‐Sensitive Dissociable Nanoscale Coordination Polymers with Drug Loading for Synergistically Enhanced Chemoradiotherapy Advanced Functional Materials ·Jingjing Liu, (unknown), Xuan Yi, Yu Chao, Departamento de Gestión, Ligeng Xu, Kai Yang, (unknown)	2017	74
14	Functionalized graphene oxide in microbial engineering: An effective stimulator for bacterial growth Carbon ·Otto Bachof, Xinxing Yang, Xiaofang Tan, Ligeng Xu, Zhuang Liu, Jie Xiao, Rui Peng	2016	28
15	Stimulation of immune systems by conjugated polymers and their potential as an alternative vaccine adjuvant Nanoscale ·Hua Gong, Jian Xiang, Ligeng Xu, Xuejiao Song, Ziliang Dong, Rui Peng, Zhuang Liu	2015	23
16	Physiological behavior of quantum dots Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology ·Ligeng Xu, Chunying Chen	2012	5
17	The dose-dependent toxicological effects and potential perturbation on the neurotransmitter secretion in brain following intranasal instillation of copper nanoparticles Nanotoxicology ·Lili Zhang, Ru Bai, Ying Liu, Meng Li, Li Bai, Liming Wang, Ligeng Xu, Laurent Le Guyader, Chunying Chen	2011	51
18	Acute pulmonary and moderate cardiovascular responses of spontaneously hypertensive rats after exposure to single-wall carbon nanotubes Nanotoxicology ·Cuicui Ge, J.M. Gustavsson, Ligeng Xu, Ru Bai, Jiangfeng Du, Lili Zhang, Yang Li, Yan-Zhong Chang, Yuliang Zhao, Chunying Chen	2011	62
19	Selective Targeting of Gold Nanorods at the Mitochondria of Cancer Cells: Implications for Cancer Therapy Nano Letters ·Liming Wang, Ying Liu, Wei Li, Xiumei Jiang, Yinglu Ji, Xiaochun Wu, Ligeng Xu, Yang Qiu, Kai Zhao, Taotao Wei, Yufeng Li, Yuliang Zhao, Chunying Chen	2010	436
20	Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods Biomaterials ·Yang Qiu, Ying Liu, Liming Wang, Ligeng Xu, Ru Bai, Yinglu Ji, Xiaochun Wu, Yuliang Zhao, Yufeng Li, Chunying Chen Hit paper breakdown →	2010	570

About Ligeng Xu

Ligeng Xu is a scholar working on Immunology, Biomedical Engineering, Biomaterials, Microbiology and Materials Chemistry, having authored 62 papers that have together received 11.8k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (30 papers), Immunotherapy and Immune Responses (17 papers), Nanoparticle-Based Drug Delivery (10 papers), Graphene and Nanomaterials Applications (10 papers), RNA Interference and Gene Delivery (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), Immune Cell Function and Interaction (7 papers) and Carbon and Quantum Dots Applications (7 papers). The work is most often cited by research in Biomaterials (3.0k citations), Biomedical Engineering (8.8k citations), Immunology (3.1k citations), Materials Chemistry (3.9k citations) and Oncology (1.3k citations). Ligeng Xu has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Zhuang Liu, Rui Peng, Jun Xu, Chao Liang, Qian Chen, Chao Wang, Yu Chao, Ziliang Dong, Xiaoqi Sun and Guangbao Yang. Their work appears in journals such as Biomaterials, Advanced Functional Materials, ACS Nano, Advanced Materials and ACS Applied Materials & Interfaces.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact